Most Recent
Arguing the interests of the self-represented applicant and group members are in conflict, Meta and Google are urging a court to shut down a class action accusing the digital giants of breaching competition law by banning cryptocurrency ads on their platforms.
A judge has grilled the former general counsel of defunct logistics company GetSwift about why he did not confront the company's directors for “bullying” other executives when they raised concerns about alleged continuous disclosure breaches.
The ACCC's rejection of a regional network arrangement between Telstra and TPG was "confusing" and the telecos might be free to vary the transaction, says a judge who is overseeing a challenge to the competition regulator's decision.
The Australian Competition and Consumer Commission has begun a sweep of social media sweep over concerns about “manipulative marketing techniques” employed by influencers.
Regenerative medicine company Mesoblast has hit back at a shareholder class action over its Remestemcel-L treatment for COVID-19, saying that some group members are barred from bringing claims because of a settlement reached in a US class action.
An investor class action against RCR Tomlinson has reached a walk-away settlement agreement with two former directors of the failed engineering company.
Cruise operator Scenic Tours has made a bid to dramatically narrow the scope of a second class action brought over a series of European cruises that went ahead in 2018 despite a record-breaking drought that saw river levels drop so low they became impassable.
The Australian Competition and Consumer Commission is weighing up undertakings proposed by Swiss construction chemical company Sika AG to alleviate concerns that its planned acquisition of Germany-based MBCC Group would be anticompetitive.
Hyundai and Kia are facing “massive compensation claims” by hundreds of thousands of car owners over allegedly defective anti-lock braking systems said to render some of the manufacturers’ most popular models potential fire hazards.
The applicant who lost a class action against animal health giant Zoetis over alleged side effects resulting from its Hendra virus horse vaccine has filed an appeal, arguing the judge should have found the vaccine was not of acceptable quality.